Back to Search
Start Over
Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3385-3385, 1p
- Publication Year :
- 2023
-
Abstract
- BACKGROUND
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64590077
- Full Text :
- https://doi.org/10.1182/blood-2023-182130